Articles by Abby Proch
-
What Sites Wish Tech Vendors (And Sponsors) Heard At SCDM But Probably Didn't
10/8/2025
During a Society for Clinical Data Management (SCDM) panel discussion, three site-side representatives discussed the challenges clinical research coordinators have executing their clinical duties amid increasingly complex data entry demands.
-
SCDM 2025: Practical Advice From Global Regulators — Including The FDA
10/6/2025
Discover what regulators from around the world, including the FDA, think should be top of mind for clinical data managers.
-
Celebrating Clinical Trials Day, Part 2: Trial Optimization In Action
5/20/2025
Celebrate Clinical Trials Day 2025 with these industry experts as they share experiences and advice related to trial design, regulatory and compliance, and outsourcing challenges.
-
Celebrating Clinical Trials Day, Part 1: Putting The Patient First
5/20/2025
Celebrate Clinical Trials Day 2025 with these industry experts sharing their experiences and advice for putting the patient first.
-
Celebrating Clinical Trials Day, Part 3: Making The Most Of Resources
5/20/2025
Celebrate Clinical Trials Day 2025 with these industry experts, who share their experiences in and advice for establishing partnerships and finding the best talent.
-
Annual SCOPE Summit Serves Up A Similar But Satisfying Menu
2/7/2025
Executive editor Abby Proch sums up her second SCOPE Summit experience.
-
4 Perspectives On What's Next In Clinical Trial Tech
12/12/2024
Clinical Leader asked clinical research professionals: “Internal, external, patient-facing, or otherwise — what clinical trial tech tool are you most excited to embrace or ditch in the new year? And why?”
-
Where Do We Stand With DCTs Heading Into 2025?
12/9/2024
Clinical Leader asked familiar voices and new faces alike: “What’s left to say, to understand, or to do with DCTs (or elements thereof) in 2025?”
-
How Did Clinical Researchers Actually Use AI In 2024?
12/5/2024
Looking ahead to 2025, Clinical Leader seeks to understand how clinical research professionals are incorporating AI into their work. So we asked them, “Simply put: Are you using any iteration of AI in your role within clinical research? If so, how and why?”
-
Psychedelic Community Reacts To FDA Committee's Critique Of Lykos' MDMA Studies
6/14/2024
An FDA advisory committee rejected the validity of therapy-assisted MDMA clinical trials conducted for the treatment of PTSD. What does the committee’s vote mean for the pursuit of MDMA and other psychedelic therapies?